Asthma is a respiratory disease which is the most common and costly among chronic diseases. It is characterized by inflammation of the airway resulting to its temporary narrowing. It results to wheezing, coughing, shortness of breath and chest tightness. It can either be triggered by an allergen or an irritant present in the environment. There is no permanent cure for asthma but it can be managed by using various medication.

A global healthcare company recently announced their filing for a fixed dose combination of mometasone furoate and formoterol fumarate in the US Food and Drug Administration.

Mometasone furoate is an inhaled corticosteroid while formoterol fumarate is a beta-2 agonist . This combination treatment is used in patients with asthma who are 12 years and older.

The combination of these two drugs will prove to be an important addition for the maintenance treatment of asthma.

It must be noted however that these fixed dose combination is only indicated as a maintenance therapy and not as a treatment for acute asthmatic symptoms. Furthermore, patients using inhaled corticosteroids may develop fungal infections of the mouth and throat. It is recommended to rinse your mouth after using an inhaler.

From Medical News Today:

“We are pleased to announce the U.S. filing of the fixed-dose combination of mometasone furoate and formoterol fumarate,” said Thomas P. Koestler, Ph. D., executive vice president and president, Schering-Plough Research Institute. “If approved by the FDA, the mometasone fuorate/formoterol combination would represent an important additional treatment option for physicians and their patients and further strengthen Schering-Plough’s portfolio of respiratory products.”

Bookmark It

Hide Sites

Tags: Asthma, formoterol fumarate, mometasone furoate

Posted in Steroid Cycles, Steroids and Anabolic Steroids, buy steroids, steroid nation